Novo CEO pressed by Senate to chop selling prices of obesity, diabetic issues medications CEO Lars Fruergaard Jørgensen informed lawmakers the corporation would think about new talks with insurers with regards to the listing prices of Wegovy and copyright whenever they pledge to maintain the medicines on their formularies. Sanders https://tysonolkhe.blogs100.com/31120139/what-does-healthcare-news-mean